Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 92%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,420
Total Claims
$935K
Drug Cost
637
Beneficiaries
$1,468
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-40%
Opioid rate vs peers
1.6% vs 2.6% avg
+38%
Cost per patient vs peers
$1,468 vs $1,068 avg
+12%
Brand preference vs peers
10.1% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.6%
Opioid Rate
162
Opioid Claims
$1,029
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,040 claims · $702K
Generic: 9,264 claims · $229K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 71 | $110K |
| Apixaban | 109 | $95K |
| Linagliptin | 64 | $44K |
| Fluticasone/Umeclidin/Vilanter | 45 | $39K |
| Semaglutide | 32 | $35K |
| Empagliflozin | 37 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 37 | $30K |
| Budesonide/Formoterol Fumarate | 48 | $26K |
| Insulin Detemir | 17 | $25K |
| Rivaroxaban | 28 | $24K |
| Semaglutide | 20 | $20K |
| Dapagliflozin Propanediol | 20 | $16K |
| Linaclotide | 17 | $12K |
| Insulin Degludec | 11 | $10K |
| Insulin Degludec | 18 | $9,895 |
Prescribing Profile
Patient Profile
75
Avg Age
59%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About